Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Losartan Potassium NDC 53002-3643 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a partial excerpt from a medical study on the medications Atenolol and Losartan Potassium, which includes a chart showing a study period of 66 months. The only quantifiable information given is an "Adjusted Risk Reduction" of 13%, but no context is provided to explain what this percentage refers to. Without further information, it is difficult to provide a clear description or interpretation of this text other than that it is related to medical research on these two drugs.*
This appears to be a comparison of efficacy between two treatments for an unidentified health condition. The percentage of patients with an event is shown for each treatment group, along with the risk reduction achieved by one treatment compared to the other. A statistical measure of significance (p-value) is also provided. The name of the condition and the details of the treatments are not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.